TLR4 and its adaptor MyD88 have been reported as oncogenic signaling in several human cancers, including HCC (Apetoh et al., 2007; Rathore et al., 2019; Zhang et al., 2020). The gene discussed is TLR4; the disease is hepatocellular carcinoma.